Vexing Volatility
<<   October/2008   >>
Sun Mon Tue Wed Thu Fri Sat
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31  

Arts
Movies
Humor
Television
Music

Business
Internet
Finance
Jobs
Investing
Economy

Computers
Software
Hardware
World
Mobile

Games
Video Games
RPGs

Health
Fitness
Medicine
Alternative

Home
Consumers
Cooking

Recreation
Travel
Food
Outdoors

Reference
Psychology
Science
Education

Regional
US
Canada
Europe

Science
NSF
Space
Technology

Society
People
Religion

Sports
Baseball
Soccer
Basketball
 
31/Oct/2008 3:16PM

The only certainty in this market appears to be volatility, as daily gyrations have reached unprecedented and exhausting levels. Unfortunately, the selling is understandable in light of a looming global recession that suggests continued negative earnings revisions for months to come.

While the S&P 500's recent valuation of only 11.8 times 2008 estimated earnings may appear cheap by historical standards, the growing likelihood of continued negative profit revisions means current valuations are likely higher than they appear. In addition, we think widespread global de-leveraging by hedge funds and others has exacerbated fundamental-driven selling. They have been scrambling to meet redemption requests and stricter margin requirements imposed by skittish prime brokers.

The U.S. consumer (whose spending accounts for roughly 70% of economic activity) is under significant pressure as a result of weakening home prices, which we believe will drop further due to a large inventory overhang. In addition, while commodity prices have declined, they remain well above year-ago levels, further crimping household balance sheets. Lastly, international economic growth, which previously helped boost both U.S. exports and S&P 500 sales, has weakened dramatically, with Europe, the United Kingdom, Canada, Japan, Australia, and New Zealand all in or nearing recession.

While equity prices should undoubtedly lead an upturn in the fundamentals, we believe the global economic and earnings outlook needs to at least show tentative signs of stabilization before any lasting rally will ensue. In light of this unprecedented global macroeconomic uncertainty, we continue to favor a defensive sector allocation.

We recommend overweighting the health care, consumer staples, and energy sectors, where we believe negative earnings revisions are least likely. Conversely, we continue to recommend underweighting areas with limited earnings visibility like consumer discretionary, industrials, and utilities. We have marketweight recommendations on financials, information technology, materials, and telecom services.

CONSUMER DISCRETIONARY

S&P Economics forecasts consumer spending will decline 0.2% in 2009, following a 0.6% expected increase in 2008. S&P equity analysts have a neutral fundamental outlook on the retailing industry, as the impact of the housing market situation and relatively higher gas prices will likely be offset by several interest rate-reductions.

CONSUMER STAPLES

S&P analysts' fundamental outlook for the sector is neutral. With commodity prices still historically elevated, credit turmoil showing no signs of abating, housing prices continuing to weaken, and the job market remaining sluggish, we believe investors may gravitate towards defensive, low-volatility sectors, such as consumer staples, with increased revenue and earnings opportunities.

ENERGY

S&P Equity Research has a positive fundamental outlook for the energy sector. We see West Texas Intermediate crude oil prices remaining elevated in 2008, averaging $110 a barrel for the full calendar year and $101 a barrel in 2009. Our fundamental outlook for the integrated oil & gas industry, which represents over half the sector’s market capitalization, is positive.

FINANCIALS

S&P analysts have a negative fundamental outlook on several industries, but we believe that Treasury Secretary Paulson's proposal to create a Federal agency similar to the Resolution Trust Corp. (RTC), which would allow troubled assets to be moved from the balance sheets of financial companies into this new institution, has lifted uncertainty surrounding the sector.

HEALTH CARE

S&P analysts have a positive fundamental outlook on the biotech industry based on an enhanced outlook for sales and earnings over the next 12 months. In addition, we have a positive fundamental outlook for the life sciences tools & services industry, based on our continued favorable view of the contract research organization group and stable growth for life science consumables.




Recent news in category
Stocks: Will the Barrage of Bad News Scare Bulls?
Banks' Credit Quality: 2009 Outlook Is Dim
Stocks Slump on Poor Jobs, Earnings News

Global recent news
AUS - Mottram leads list of
Curried Zucchini Soup Recipe
Image gallery: 15 great gadgets for the back-to-school crowd

31/Oct/2008 3:00PM

31/Oct/2008 12:18PM

31/Oct/2008 10:40AM

31/Oct/2008 10:30AM

31/Oct/2008 10:19AM

Copyright © 2006 Rootio Ltd. All rights reserved.